Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | HER2 CAR-T cells |
Trade Name | |
Synonyms | ERBB2 (HER2) CAR-T cells|ERBB2 CAR-T cells |
Drug Descriptions |
HER2 CAR-T cells are T-cells that are modified to express a chimeric antigen receptor recognizing ERBB2 (HER2), which may result in increased death of ERBB2 (HER2)-expressing tumor cells upon infusion (PMID: 25800760, PMID: 25711536). |
DrugClasses | HER2 (ERBB2) Immune Cell Therapy 3 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cyclophosphamide + Fludarabine + HER2 CAR-T cells + Nivolumab | Cyclophosphamide Fludarabine HER2 CAR-T cells Nivolumab | 0 | 0 |
Cyclophosphamide + Fludarabine + HER2 CAR-T cells + Pembrolizumab | Cyclophosphamide Fludarabine HER2 CAR-T cells Pembrolizumab | 0 | 1 |
HER2 CAR-T cells | HER2 CAR-T cells | 0 | 4 |
HER2 CAR-T cells + Nivolumab | HER2 CAR-T cells Nivolumab | 0 | 1 |